Nektar Therapeutics $73.02 (-2.90, 3.97%)

NASDAQ
96% success, from Analysis 19* of this Model (*Public)
Summary
LONGBUY: Best moves 13 which gains 663.6, return on capital invested 8.3%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action